Difference between revisions of "Part:BBa K2632009"

Latest revision as of 15:35, 17 October 2018

OmpA coding sequence in Salmonella(Para-OmpA-RGD).

We use BBa_J36850 (Lpp-OmpA(46-159)-Streptavidin wild-type) to do the improvement. We add the RGD sequence at the same position of that in Salmonella, which can display the RGD on the outside of OmpA.

Reference

Park, S. H. et al. RGD peptide cell-surface display enhances the targeting and therapeutic efficacy of attenuated Salmonella-mediated cancer therapy. Theranostics 6, 1672–1682 (2016).

Sequence and Features

Assembly Compatibility:

10
COMPATIBLE WITH RFC[10]
12
COMPATIBLE WITH RFC[12]
21
INCOMPATIBLE WITH RFC[21]
Illegal BamHI site found at 293
23
COMPATIBLE WITH RFC[23]
25
COMPATIBLE WITH RFC[25]
1000
COMPATIBLE WITH RFC[1000]

@@ Line 4: / Line 4: @@
 <html>
-We use BBa_J36850( Lpp-OmpA(46-159)-Streptavidin wild-type) to do the improvement. We add the RGD sequence at the same position of that in Salmonella, which can display the RGD on the outside of OmpA.
+We use BBa_J36850 (Lpp-OmpA(46-159)-Streptavidin wild-type) to do the improvement. We add the RGD sequence at the same position of that in <i>Salmonella</i>, which can display the RGD on the outside of OmpA.
 <h3>Reference</h3>
 <p>
-Park, S. H. et al. RGD peptide cell-surface display enhances the targeting and therapeutic efficacy of attenuated salmonella-mediated cancer therapy. Theranostics 6, 1672–1682 (2016).</p>
+Park, S. H. et al. RGD peptide cell-surface display enhances the targeting and therapeutic efficacy of attenuated <i>Salmonella</i>-mediated cancer therapy. Theranostics 6, 1672–1682 (2016).</p>
 </html>
 <!-- Add more about the biology of this part here